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Strengths and limitations of this study
 ► In the largest randomised controlled trial of a rec-
ommended patient- centred model of care for people 
with multimorbidity, we conducted a comprehensive 
process evaluation to examine implementation fi-
delity in case of a null result and to inform future 
implementation.
 ► We used mixed methods to evaluate multiple as-
pects of implementation and a wide range of factors 
that might influence implementation.
 ► Although distinguishing between implementation 
failure and intervention failure is recommended in 
null trials to avoid needlessly discarding a promising 
intervention, the distinction is difficult to apply when 
aspects of intervention design contribute to imple-
mentation deficiencies.
 ► By investigating reasons for implementation de-
ficiencies, and distinguishing between potentially 
modifiable and non- modifiable reasons, we have 
instead provided information that is potentially more 
valuable than dichotomising between implemen-
tation failure and intervention failure for informing 
decisions about wider implementation or the need 
for further research.
AbStrACt
Objectives During a cluster randomised trial, (the 3D 
study) of an intervention enacting recommended care 
for people with multimorbidity, including continuity of 
care and comprehensive biennial reviews, we examined 
implementation fidelity to interpret the trial outcome and 
inform future implementation decisions.
Design Mixed- methods process evaluation using 
cross- trial data and a sample of practices, clinicians, 
administrators and patients. Interviews, focus groups 
and review observations were analysed thematically and 
integrated with quantitative data about implementation. 
Analysis was blind to trial outcomes and examined context, 
intervention adoption, reach and maintenance, and 
delivery of reviews to patients.
Setting Thirty- three UK general practices in three areas.
Participants The trial included 1546 people with 
multimorbidity. 11 general practitioners, 14 nurses, 7 
administrators and 38 patients from 9 of 16 intervention 
practices were sampled for an interview.
results Staff loss, practice size and different administrative 
strategies influenced implementation fidelity. Practices 
with whole administrative team involvement and good 
alignment between the intervention and usual care generally 
implemented better. Fewer reviews than intended were 
delivered (49% of patients receiving both intended reviews, 
30% partially reviewed). In completed reviews >90% of 
intended components were delivered, but review observations 
and interviews with patients and clinicians found variation in 
style of component delivery, from ‘tick- box’ to patient- centred 
approaches. Implementation barriers included inadequate 
skills training to implement patient- centred care planning, 
but patients reported increased patient- centredness due to 
comprehensive reviews, extra time and being asked about 
their health concerns.
Conclusions Implementation failure contributed to lack of 
impact of the 3D intervention on the trial primary outcome 
(quality of life), but so did intervention failure since modifiable 
elements of intervention design were partially responsible. 
When a decisive distinction between implementation failure 
and intervention failure cannot be made, identifying potentially 
modifiable reasons for suboptimal implementation is 
important to enhance potential for impact and effectiveness of 
a redesigned intervention.
trial registration number ISRCTN06180958
IntrODuCtIOn
The increasing prevalence of multimorbidity, 
driven by ageing populations across the 
world, is a major challenge to health services. 
There is broad consensus about how primary 
care for people with multimorbidity should 
be organised,1–3 but little evidence about 
the effectiveness of recommended strate-
gies. Reflecting this absence of evidence, the 
2016 National Institute of Health and Care 
Excellence Multimorbidity clinical guide-
line recommended more research on how 
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Figure 1 3D intended intervention work and core components. 3D, GP, general practitioner.
best to organise primary care to address the challenge 
of improving care for people with multimorbidity.3 In 
the largest trial to date of an intervention based on the 
consensus of opinion about best practice for multimor-
bidity care, the 3D study evaluated a patient- centred 
approach for the people with multimorbidity, defined for 
this trial as people with three or more long- term condi-
tions on a disease registry. The approach included conti-
nuity of care and regular holistic reviews (3D reviews) in 
primary care (general practices in the UK) with a focus 
on addressing quality of life, mental as well as physical 
health, and polypharmacy. The hypothesis was that this 
would improve patient- centred care, reduce treatment 
burden and illness burden and improve quality of life 
(the trial primary outcome).4
Process evaluation of trials evaluating complex inter-
ventions can inform decisions about the wider imple-
mentation and applicability of those interventions. A 
comprehensive process evaluation can help interpret 
trial results and inform real- world implementation5 6 by 
providing explanations when interventions are not effec-
tive.7 This may be because of intervention failure (the 
intervention was delivered as intended but did not 
improve outcomes, so should not be implemented) and/
or implementation failure (the intervention was inad-
equately implemented and so might need additional 
research to further examine effectiveness).8 However, 
distinguishing implementation and intervention failure 
is often not straightforward9 10 and may require detailed 
examination of implementation fidelity.
We have previously reported baseline data from the 3D 
study,11 main trial findings12 13 and analysis of the patient- 
centredness of the 3D review.14 At baseline, many prac-
tices had already combined multiple long- term condition 
reviews into one appointment but other recommended 
care1 3 was less evident. For example, only 10% of patients 
were aware of receiving a care plan and 35% were rarely 
or never asked what was important to them in managing 
their health.11 The main trial results showed no effect 
from the 3D intervention on the primary outcome of 
health- related quality of life (HRQOL) or other related 
secondary outcomes such as well- being and treatment 
burden, but a consistent beneficial effect on patients’ 
experience of care as more person centred.12 Analysis 
of observational and interview data about intervention 
delivery indicated that the main reasons for the perceived 
increase in patient- centredness were that when patients 
attended for an intervention review, they were first asked 
about their most important health concerns and then 
given a longer, comprehensive review encompassing 
all health issues.14 The aim of this paper is to examine 
whether the measured lack of effect on the primary 
outcome in the 3D trial was due to implementation or 
intervention failure, and thereby inform future interven-
tion development and evaluation.
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Figure 2 Process evaluation design and research questions (research stages addressed in this paper are shown in blue). 3D; 
GP, general practitioner.
MethODS
Setting: - the 3D study
The intervention and trial evaluation are described briefly 
here, having been reported in detail elsewhere.4 12 13 The 
core components of the intervention included offering 
greater continuity of care and 6 monthly, two- part patient- 
centred, comprehensive health reviews, conducted by a 
named nurse and general practitioner (GP) and under-
pinned by a purpose- designed electronic template 
(figure 1). A pharmacist also completed an electronic 
medication review. Practices were expected to deliver two 
complete reviews to every participating patient during 
the trial, including all review components. However, prac-
tices could decide the detail of how they would provide 
the reviews, enhance continuity of care and reduce the 
number of review appointments. Administrators and 
clinicians nominated by the practices received two short 
(2–3 hours) training sessions from the trial team on the 
intervention’s rationale and the use of the computer 
template. Online supplementary appendix 1 shows the 
TIDieR checklist15 for the intervention design. Figure 1 
details the work that administrative staff, clinicians and 
pharmacists were expected to do to deliver the interven-
tion. Sixteen general practices received the intervention 
compared with 17 control practices, with 1546 partici-
pating patients.4 However, because of staffing crises, one 
intervention practice stopped delivering the intervention 
and withdrew from the process evaluation.
Patient and public involvement
A patient and public involvement group was set up during 
the development of the trial intervention to ensure that 
it met the perceived needs of people with multimorbidity. 
The group was actively involved throughout the trial in 
multiple ways, as reported by Mann et al.16
Process evaluation design
The design is briefly reported here as a detailed descrip-
tion is provided in our earlier paper.17 We based the design 
on a process evaluation framework for cluster randomised 
trials,18 and also considered UK Medical Research 
Council guidance for process evaluation of complex 
interventions.10 This, rather than qualitative methodology 
criteria, underpins the rigour of the research as our focus 
was to ensure a comprehensive process evaluation that 
examined all aspects of intervention implementation that 
might affect the results of the trial. As such, the interview 
schedules were semi- structured to elicit specific informa-
tion to answer the process evaluation research questions 
and the size of our qualitative sample was determined by 
information power19 regarding implementation variation 
and the reasons for it, rather than data saturation.
We based the process evaluation on a logic map 
describing the intervention design and used the logic 
map to inform assessment of implementation fidelity (the 
extent to which practices implemented the intervention 
as the researchers intended).17 The assessment covered 
adoption of the 3D intervention (implementation of the 
organisational components of the intervention); delivery 
of 3D reviews to patients; maintenance (whether delivery 
is sustained over time) and reach (the number of partic-
ipants who receive the intervention) (figure 2), and 
the important influence of context on implementation 
fidelity, maintenance and reach.20–23
Data collection
Qualitative data collection in selected practices
Intervention practices were sampled at different stages 
for qualitative data collection (table 1). Four practices 
were initially purposefully sampled during early stages of 
the trial, using baseline data and observation of practice 
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Table 1 Data from intervention practices used for this study
Data
Sampled intervention 
practices Data sources Data used to examine
Electronic data capture All 3D electronic template recording 
of reviews completed and review 
components delivered to all 
patients
Reach and maintenance
Fidelity of delivery of 
intervention components to 
patients
Administrative survey All Research team completed 
questionnaire about organisation 
of reviews in all intervention 
practices
Adoption, reach and 
maintenance
Baseline interviews Beddoes, Davy, Harvey, 
Lovell
4 administrators, 4 nurses, 5 GPs Individual practice context 
to understand adoption and 
reach.
3D review observations Beddoes, Davy, Harvey, 
Lovell, Cabot, McReady, 
Guppy, Carpenter
13 nurses, 15 GPs, 22 patients* Variation in delivery of 
intervention components to 
patients
Postreview debriefs and 
informal interviews
Beddoes, Davy, Harvey, 
Lovell, Cabot, McReady, 
Guppy, Carpenter
12 nurses, 7 GPs, 10 patients Variation in delivery of 
intervention components to 
patients
Maintenance of intervention 
delivery
Patient focus groups Beddoes, Davy, Harvey, 
Lovell
22 patients† Variation in delivery of 
intervention components to 
patients
End- of trial interviews Beddoes, Davy, Harvey, 
Lovell, Blackwell
4 administrators, 6 nurses, 5 
GPs, 7 patients
Variation in delivery of 
intervention components to 
patients.
Maintenance of intervention 
delivery
*6 patients were observed for both parts of review.
†2 focus groups of 3 patients, 1 focus group of 7 patients and 1 focus group of 7 patients and 2 carers.
GP, general practitioner.
team training, for detailed qualitative investigation of 
all aspects of implementation, including context, adop-
tion, delivery and maintenance. This sampling reflected 
our assumptions that (1) larger practices may have lower 
continuity of care and a lower proportion of clinicians 
taking part in 3D, which may influence implementation 
and (2) practices whose care for patients with multi-
morbidity already reflected aspects of the 3D approach 
may adopt 3D more readily. These four practices were 
included in every stage of data collection. An additional 
five practices were responsively sampled at later stages for 
focused observation of clinicians’ style of delivery of 3D 
reviews and to examine variations in models of delivery 
that emerged during the trial. In total 9 of the 16 inter-
vention practices were sampled.
All intervention practices were given pseudonyms 
to preserve anonymity. Data collected included: inter-
views with practice staff; non- participant observation of 
3D reviews with follow- up interviews with clinicians and 
patients; and focus groups and interviews with patients 
(table 1), all of which were audio recorded. The qual-
itative data were almost all collected by CM, a female 
qualitative researcher experienced in focus groups 
and interviews and with clinical nursing experience, 
including as a practice nurse. Five observations and 
one interview were carried out by a female GP gaining 
experience in qualitative research. The interview topic 
guides and observation checklist are shown in online 
supplementary appendix 2. All the analyses were carried 
out by CM with support from BG, a GP, health services 
researcher and process evaluation methodologist, and 
AS, a highly experienced qualitative and process evalua-
tion researcher.
Interviews with practice staff: At baseline, interviews in 
the four initially sampled practices with the 3D lead GP, 
the lead nurse and the key administrator explored usual 
care, initial reactions to the intervention and implementa-
tion arrangements. Interviews at the end of the trial in the 
same four practices, and in a fifth, responsively sampled 
practice where a nurse practitioner delivered all reviews, 
explored experience of delivering the intervention and 
maintenance. These interviews lasted 15–50 min. Most 
individuals were interviewed at both the beginning and 
end of the trial to achieve a longitudinal perspective on 
implementation and to see how their initial response to 
the intervention changed in light of their experience 
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of implementing it, but there were also a few single 
interviews.
Observation of 3D reviews with follow- up interviews: 
Twenty- eight 3D reviews were observed and recorded 
in the four initially sampled practices and in four of 
the responsively sampled practices, including one in 
which a research nurse, rather than a practice nurse, 
conducted most of the part 1 reviews. Observation 
notes were informed by an observation checklist (online 
supplementary appendix 2). The checklist was based on 
the intervention components and directed attention to 
whether components were delivered and the manner of 
their delivery. Where possible, brief follow- on interviews 
with the clinician and/or patient whose review had been 
observed were completed on the same day. These inter-
views lasted 5–24 min.
Focus groups and interviews with patients: In the four 
initially sampled practices, patients varying in health 
status and satisfaction with care according to baseline 
questionnaire data were invited to focus groups or indi-
vidual interview towards the end of the trial, to explore 
their experience of receiving the intervention. One focus 
group per practice took place, lasting about 1 hour. 
Patients preferring individual interviews were interviewed 
for 20–50 min in a convenient location, usually their own 
home. All the focus groups and interviews were carried 
out by CM.
Online supplementary appendix 3 shows the COREQ 
checklist24 for qualitative methodology and provides addi-
tional detail.
Quantitative data collected from all intervention practices
Data about 3D review completion were extracted each 
month from the routine electronic medical records to 
evaluate intervention reach, delivery and maintenance.4 17 
The data included dates of reviews, who had completed 
the review, and whether core elements were recorded as 
delivered in the 3D review template. In the first part of 
the review delivered by a nurse, data included descrip-
tion of patients’ main concerns, pain levels, depression 
screening, and the creation and printing of a patient 
agenda. The template also recorded the pharmacist’s 
completion of a medication review, their recommenda-
tions and whether these had been noted by the GP. In 
the second part of the review delivered by a GP (except 
in one practice), recorded data included medication 
adherence and description of at least one main problem 
in the health plan, together with patient and GP actions 
to address the problem. Finally, the software recorded 
whether an agreed health plan had been printed.
Survey data collected in all intervention practices
Researchers in each trial area completed a purpose- 
designed administrative survey about the way 3D 
reviews were organised in all intervention practices. The 
survey included the proportion of the administrative 
team involved in 3D, how patients were identified and 
contacted, and whether practices facilitated 3D patients 
seeing their named GP at appointments other than 3D 
reviews.
Data analysis
All audio recordings of qualitative data (interviews, focus 
groups and consultation recordings) were professionally 
transcribed, then the transcript was checked against the 
recording, anonymised and annotated with observation 
notes. The annotation process aided interpretation of 
the data and illuminated the manner of delivery in the 
recorded consultations. We applied qualitative descrip-
tion methodology to write individual accounts25 of context 
and adoption of the intervention in the four practices 
initially sampled for detailed examination,13 and cross- 
case thematic analysis26 to identify recurring issues rele-
vant to intervention adoption, delivery and maintenance 
in all nine selected practices. The data were analysed in 
parallel with data collection, so that emerging issues were 
incorporated into future data collection. For the thematic 
analysis, NVivo V.11 software (QSR International) was 
used to facilitate both deductive coding derived from 
intervention components and inductive coding derived 
from the data,26 allowing the identification of both antic-
ipated themes (eg, those relating to the key components 
of the intervention) and emergent themes across sampled 
practices. Qualitative analysis was led by CM with input 
from AS, LW and BG, who commented on the developing 
coding framework, double coded a sample of transcripts 
and agreed the final themes. Additionally, to further 
enhance trustworthiness and credibility of findings, two 
members of the patient and public involvement group 
each coded four transcripts to check interpretation of the 
data from the patient perspective. Quantitative data were 
analysed descriptively by CM and KC and integrated with 
qualitative data.
All process evaluation data collection and analyses were 
done blind to the trial outcome, so that interpretation 
would not be influenced by knowing the results of the 
primary outcome.
reSultS
The results examine (1) adoption of the intervention by 
practices, (2) reach and maintenance and (3) delivery of 
reviews to patients. In quotes, staff and patients are iden-
tified by practice pseudonym, role and a number.
Adoption: organisational components
The two core components of organisational adoption 
were continuity of care and arranging the two- part 3D 
reviews.
Continuity of care
Practices were asked to allocate a named GP to 3D 
patients for their reviews and for any appointment 
between reviews. Continuity of care was evaluated as a 
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Table 2 Intervention practices
Practice Practice size
Combined 
reviews at 
baseline* Admin involvement
3D review 
organisation Reach
Qualitative data 
collection§
Lovell 4000 patients
4 GPs, 2 nurses
All combined 1 administrator. All 
aware
Appointment sent, 
review appointments 
paired
First review 94%
Second review 93%
In depth. All 
elements
Tothill 10 000 patients
40 GPs, 4 
nurses
Some combined All Appointment sent, 
review appointments 
separate
First review 92%
Second review 86%
None
Macready 6000 patients
6 GPs, 2 nurses
All combined 1 administrator. All 
aware
Appointment sent, 
review appointments 
paired
First review 92%
Second review 50%
Observation and 
postreview informal 
interview
Dunbar 15 000 patients
16 GPs, 5 
nurses
All combined All Letter inviting patient 
to call, review 
appointments paired
First review 90%
Second review 75%
None
Cabot 10 000 patients
12 GPs, 5 
nurses
Some combined Research nurse only Appointment sent, 
review appointments 
separate
First review 83%
Second review 74%
Observation and 
postreview informal 
interview
Beddoes 5500 patients,
4 GPs, 3 nurses
All combined All Letter inviting patient 
to call, review 
appointments separate
First review 80%
Second review 82%
In depth. All 
elements
Guppy 8000 patients
6 GPs, 3 nurses
All combined 1 administrator. All 
aware
Appointment sent, 
review appointments 
paired
First review 80%
Second review 76%
Observation and 
postreview informal 
interview
Penn 10 500 patients
9 GPs, 3 nurses
Some combined 1 administrator. All 
aware
Phone call to patient, 
review appointments 
paired
First review 80%
Second review 47%
None
Harvey 15 000 patients
13 GPs, 4 
nurses
Some combined All Appointment sent, 
review appointments 
sometimes separate
First review 77%
Second review 44%
In depth. All 
elements
Priestman 13 500 patients
10 GPs, 3 
nurses
All combined All Letter inviting patient 
to call, review 
appointments paired
First review 75%
Second review 45%
None
Sharples 4500 patients
4 GPs, 2 nurses
None combined All Letter inviting patient 
to call, review 
appointments separate
First review 71%
Second review 67%
None
Martineau 5000 patients
4 GPs, 2 nurses
Some combined 2 administrators. 
Others unaware
Phone call to patient, 
review appointments 
paired
First review 69%
Second review 53%
None
Carpenter 14 500 patients
12 GPs, 4 
nurses
All combined Unsure if all aware Letter inviting patient 
to call, review 
appointments paired
First review 67%
Second review 50%
Observation and 
postreview informal 
interview
Blackwell 13 500 patients
9 GPs, 7 nurses
All combined Nurse and 
administrator. Others 
unaware.
Letter inviting 
patient to call, nurse 
completed both parts 
of review
First review 66%
Second review 9%
End of trial 
interviews
Davy 14 500 patients
12 GPs five 
nurses
Some combined 2 administrators. 
Others unaware
Appointment sent, later 
review appointments 
separate
First review 38%
Second review 0%
In depth. All 
elements
*Combined reviews means reviews were purposely arranged to include all long- term conditions where there was a nurse- led clinic.
†Paired means that nurse and GP appointments made at the same time but could take place on different days.
‡See table 1 for details of qualitative data collected.
GP, general practitioner.
secondary outcome for the trial and, measured using 
the Continuity of Care index,27 increased slightly in 
the intervention arm.12 However, some patients experi-
enced reduced continuity because their GP left during 
the trial. Others were allocated a different GP for the 
intervention, either to share workload or because their 
usual GP was not participating in 3D. These patients 
often continued to see their usual GP for appointments 
other than reviews.
[My usual GP had to get changed. There’s three doc-
tors in our practice and they were doing I think 12 
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Table 3 Quantitative evaluation of reach
No (%) of 3D reviews 
delivered
Practice level analysis n=16 practices
Reach (% expected number 
of reviews delivered)
  First review Median 66% (range 38%–
94%)
  Second review Median 47% (range 0%–
93%)
Patient level analysis n=797
Delivery of 3D nurse and GP 
reviews*
  Two 3D reviews with both 
GP and nurse (full)
390 (49%)
  One 3D review with both GP 
and nurse (partial)
205 (26%)
  Other (eg, nurse review but 
no GP review) (partial)
31 (4%)
  No 3D reviews (none) 171 (21%)
*622 (78%) patients had at least one nurse review; 599 (75%) 
had at least one GP review. 390 (49%) patients received a ‘full’ 
intervention (defined as having two reviews, with each review 
involving a nurse and a GP appointment which could be on the 
same day or different days that is, four appointments in total) in the 
15 months of follow- up. 21% received no intervention.
GP, general practitioner.
patients, so it was split between three doctors. So I 
had to go with [GP2]. (Focus group Lovell Patient 8)
The four initially sampled practices (Beddoes, Davy, 
Harvey and Lovell) provided insight into contextual influ-
ences. Harvey already had a ‘personal list’ system with 
high continuity, but during the trial this was disrupted 
when several GPs left the practice. Beddoes supported 
3D participants to see their allocated GP between reviews. 
At Davy, continuity was poorly implemented due to staff 
loss and because receptionists were unaware of 3D. Lovell 
continued with their usual system, which they felt deliv-
ered adequate continuity of care.
Most people see the doctor they want to see, so I think 
from a continuity point of view we know our patients 
very well and we’ve all been here a long time. [Group 
interview Lovell GP1]
Arranging reviews
Administrative survey data from 15 intervention practices 
showed variation in the way practices arranged reviews 
(table 2). Ten practices involved the whole administra-
tive team, but in four, one or two administrators arranged 
3D reviews in isolation. Reach was lowest in these four 
practices. In the remaining practice (Cabot), a dedicated 
research nurse arranged all the reviews, bypassing the 
administrative team. Notably, some 3D patients received 
the 3D reviews in addition to, rather than instead of their 
usual individual condition reviews, as intended.
I think there became a problem where patients were 
being invited in for their 3D and then a couple of 
months later, they'd get invited in for their diabetes 
and their asthma because one person up there wasn’t 
talking to the other one. [Interview Blackwell Nurse 
1]
At Lovell and Harvey, existing arrangements for long- 
term condition reviews (one of the sampling criteria) 
underpinned the 3D review arrangements, reducing 
confusion. At Davy, the two administrators involved 
had to set up a different system for 3D patients. Being 
a large practice in which the rest of the administrative 
team were unaware of 3D requirements, difficulties arose 
when patients needed to re- arrange the appointment. 
At Beddoes, clinical and administrative staff decided 
collectively how they would implement the administrative 
aspects of 3D, but it differed from usual arrangements.
We’d had a team meeting after the training with the 
senior nurse and the GPs to decide what was the best 
way forward and then I met with the admin team to 
say, What would you like to see on your screen so that 
you know they’re part of the 3D study and so that you 
know about the appointments? (Interview Beddoes 
practice manager)
Overall, adoption was inconsistent, affected by prac-
tices’ choices in respect of continuity and arrangements 
for reviews. Duplication of reviews in some practices 
suggests difficulty in testing effectiveness of an interven-
tion in a research situation that involves a short- term 
alteration to accustomed methods of providing care, that 
affects only a subset of patients.
reach and maintenance
Table 3 shows mean reach in all intervention practices. 
We defined intervention reach in terms of receipt of 
planned 3D reviews by participating patients. Reach 
varied between practices from 38% and 94% (median 
66%) of all recruited patients in a practice receiving both 
the nurse and GP appointments in first round reviews, 
and between 0% and 93% (median 47%) in second 
round reviews. Initial implementation of the intervention 
was, therefore, not well- maintained.
In the four initially- sampled practices, the qualita-
tive data revealed contextual factors reducing the time 
window for delivering reviews. Lovell started delivering 3D 
reviews straight after training and had the highest reach 
of any practice in the intervention arm. The other three 
practices delayed starting, Davy because of the sudden 
loss of three of their long- term condition nurses and two 
GPs, Harvey because they were changing their system for 
sending letters re- calling patients for long- term reviews, 
and Beddoes because of staff sickness. Once started, Davy 
administrators struggled to organise reviews, hampered 
by ongoing sickness in the nursing team, and only 
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Table 4 Quantitative evaluation of component delivery
No (%) of each element of the 3D review delivered
Delivery of pharmacist medication review 607/797 (76)
For those with at least one GP or nurse review
Most important problem noted (patient agenda)* 616/622 (99)
EQ- 5D pain question noted (quality of life)* 611/622 (98)
PHQ-9 depression screening noted* 599/622 (96)
Patient agenda printed* 579/622(93)
Medication adherence noted† 506/599 (84)
First patient problem noted† 590/599 (98)
Noted ‘what patient can do’ for first problem (health plan)†
Noted ‘what GP can do’ for first problem (health plan)† 559/599 (93)
3D health plan printed† 461/599 (77)
*Components delivered in the nurse part of the review of which 622 took place. If one patient had two reviews, this component was delivered 
in at least one.
†Components delivered in the GP part of the review of which 599 took place. If one patient had two reviews, this component was delivered in 
at least one.
GP, general practitioner.
managed to schedule 25% of the reviews required. The 
greatest challenge was accommodating paired reviews 
within over- stretched appointment schedules.
And I think because you’re trying to tally it up with 
the doctor and the nurse, trying to find the time with 
the nurse if they’ve got more than one problem … 
and again they’re not full time; they work part time. 
[Interview Davy Administrator 1]
Difficulties with arranging appointments reinforced 
practices’ initial fears that the time demand and work-
load of implementing the 3D intervention would be too 
great. One suggestion made by GPs was that patients 
could be selected using more stringent criteria to reduce 
the overall number and maximise the chance of benefit. 
Another suggestion, from nurses, GPs and patients, was 
that the reviews need not involve the GP every time and/
or could be shorter. Some comments suggested a lack of 
perceived value of the second- round reviews and that a 
second- round review with the nurse alone would be more 
time- efficient.
I know they need to be reviewed but do they need 
to be reviewed by nurse and GP?
… because if we saw them for review and they were 
happy. Do they honestly need to see the GP to say 
“Are you still happy, like from last week”? (Interview 
Guppy Nurse 1)
Practices may therefore have been less motivated to 
arrange second reviews, and one practice reported that 
fewer patients responded to the invitation to attend them.
As a practice we’ve actually struggled to get them in 
for their second ones … we’ve written to them all 
twice – probably 30% of them haven’t booked in and 
so we have had a bigger DNA rate for the second ones 
than the first ones. (Interview Beddoes GP1)
Overall, reach and maintenance were lower than 
intended, indicating a degree of implementation failure. 
Attention to context showed this was mainly a result of 
unanticipated events (eg, staff loss or sickness) affecting 
practice capacity. However, aspects of intervention design 
(eg, the inclusion of two reviews in 1 year with both nurse 
and GP each time) may also have impacted reach and 
maintenance.
Delivery of 3D review components
In 3D reviews that took place, each of the interven-
tion components (see figure 1) detected by the elec-
tronic search were completed in at least 92% of the 
delivered reviews, except medication adherence which 
was completed in 84% and printing the health plan in 
77% (table 4 and online supplementary appendix 4). 
The qualitative data provided insight into reasons for 
less consistently recorded components but also found 
evidence of significant variation in the manner of 
delivery suggesting that the high recorded component 
completion concealed some tick- box compliance. Vari-
ation in the patient- centredness of review component 
delivery has been reported in more detail in a previous 
paper14; here we focus primarily on implementation 
fidelity.
Eliciting and documenting the patient’s concerns (most important 
problem noted)
The most consistently delivered component (99% 
completion) (table 4), was asking patients about the 
health problems important to them. Nurses often invited 
disclosure of all health concerns, large or small.
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She said to me, 'Is there anything you want to dis-
cuss with me at all, anything?' [Focus group Beddoes 
Patient 4)]
Some GPs and nurses commented on the value and 
novelty of asking about all patients’ health concerns at 
the start of the consultation14 but others were conscious 
of their clinical responsibility for managing the long- 
term conditions. Therefore, they preferred to separate 
the long- term conditions from health concerns they 
viewed as more trivial, or disabilities not amenable to 
change.
They want to discuss … the things that are happen-
ing to them at that particular moment … they’ve got 
a bad cold, or the cat’s died or something else and 
they don’t want to talk about their diabetes or their 
COPD. [Interview Beddoes GP3]
There was also observed variation in how patient’s 
concerns were elicited, recorded in the agenda and 
addressed in the health plan. The printed agenda was 
intended to reflect the patient’s perception of health 
problems (as well as clinical concerns), but nurses were 
often observed to reframe patients’ problems into more 
medical terms. For example, one patient said: ‘I can’t 
take these naproxen now because … they’ve upset my 
stomach’ and the nurse recorded ‘gastric problems’. 
This medicalisation of problems may have contributed to 
some patients’ perception that the agenda was simply a 
means for the nurse to communicate their findings to the 
GP, rather than an agenda that the patient owned.
They just went through everything, all the problems, 
the nurse did and just wrote this report out for [GP2]. 
[Focus group Beddoes Patient 11]
Quality of life and depression screening
Although completion was high, observation revealed that 
components that had a range of set answers were some-
times delivered in a ‘tick- box‘ way that did not invite 
dialogue. This most commonly happened with template 
questions about quality of life and depression screening. 
It usually occurred when the nurse anticipated no prob-
lems being revealed but in interview some nurses also said 
that they lacked confidence in talking to patients about 
mental health.
Printing patient agenda
The patient agenda was printed in the vast majority of 
cases (93%) (table 4) but problems with printing were 
occasionally observed and one nurse said she asked 
patients if they wanted it and that they declined. This 
may have reflected a perceived lack of ownership of the 
agenda by the patient.
Would you like a copy? And they’re like, it’s fine…
Nobody has wanted a copy. [Interview Davy Nurse 
1]
Medication adherence
The completion rate of this component was lower at 84% 
but the qualitative data did not reveal why, other than 
some GPs’ preference to complete the template after the 
review, which may have meant they forgot to ask about it. 
On the contrary, there was evidence of some support for 
this component among GPs.
I do think the thing about tablets that patients take 
and which ones they don’t like, if any, is useful. 
[Interview Lovell GP1]
Collaboratively agreeing a plan
Health plans were intended as collaborative agreements 
between patient and GP, recording identified problems 
and specific actions for patient and GP to address each 
recorded problem. The patient and GP actions were 
well completed (93% and 92%, respectively, for the first 
problem) but the health plan was printed less frequently 
(77%) (table 4). This may reflect GPs apparent dislike 
of the health plan and a perceived lack of value, as well 
as observed technical difficulties printing the plan. Inter-
view data included reservations about the formulation of 
the health plan, which may have made GPs reluctant to 
give them to patients.
I felt it was almost that you were actually chiding 
them in some ways, to say, ‘You should do this, should 
do that. … It’s almost like when we were at primary 
school, taking home your homework tasks and goals 
for the week’. [Group interview Lovell GP3]
During observations, a collaborative dialogue based on 
patients’ chosen goals was seldom generated, and most 
plans were based on actions suggested by the GP. Some 
GPs commented that patients had not given prior thought 
to what they wished to address and that sometimes it was 
difficult to identify problems to include in the plan.
That’s where I think perhaps them thinking in ad-
vance about their goal setting would help aid the 
conversation because often they say ‘No, no there’s 
nothing I want to discuss’ and you eventually tease 
out one or two things from them. [Interview Beddoes 
GP1]
Some clinicians felt that the training provided 
by the trial team was insufficient to enhance skills 
required for agenda setting and especially collaborative 
action- planning.
I think some kind of communication training … 
would have been useful…there was a little bit about 
goal setting and confidence skills but there was no 
real practical element to it so in some ways you’re 
testing what we already do but in a different context. 
[Interview Lovell GP1]
Others would have liked some training follow- up to 
check if they were delivering the intervention as intended, 
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and additional training prior to the second round of 
reviews to ensure they were ‘doing it right’.
In conclusion, although the quantitative data indi-
cated that the intervention components were delivered 
for a high proportion of patients receiving reviews, the 
qualitative data showed that delivery style varied in ways 
that could sometimes compromise their function. Some 
components, such as creating the health plan, could have 
benefited from more training.
DISCuSSIOn
Summary of findings
The process evaluation identified that implementation 
was somewhat deficient in adoption (arranging the requi-
site number of 3D reviews, ensuring continuity of care, 
reducing the overall number of reviews) and aspects of 
delivery (creating health plans), but most delivered reviews 
included all components. Reasons for incomplete imple-
mentation included unexpected pressure on resources, 
implementation choices made by practices (including 
not involving the entire administrative team), and insuf-
ficient training for using patient- centred approaches. 
During delivery of reviews to patients, using the template 
was the key to maintaining ‘fidelity of form’, but varia-
tion in the patient- centredness of delivery sometimes 
undermined ‘fidelity of function’.28 The overall predic-
tion made by the process evaluation team while blind 
to the trial results was that the intervention would have 
improved patient experience in patients who received 
3D reviews, but not changed HRQOL (the findings were 
presented and this prediction made at the trial steering 
committee meeting immediately before unblinding). 
The prediction of improved experience was based on 
the positive feedback from patients in focus groups and 
interviews suggesting improvements in their perceptions 
of care. The prediction of unchanged HRQOL was based 
on limited engagement of patients in the health plans 
(observed and described by clinicians), a lack of evidence 
of major changes to quality of care and feedback from 
administrators and clinicians about difficulties organising 
reviews. The trial results confirmed these predictions,12 
which increase our confidence in the process evaluation 
findings.
Strengths and weaknesses
Strengths include predesigning the process evaluation 
based on a published framework for process evaluation of 
cluster randomised trials10 17 18 covering all trial stages and 
maintaining responsiveness to emerging information. 
This maximised the likelihood that all factors that might 
influence implementation fidelity, including context, 
were considered.7 Data of varying and complemen-
tary types were collected from a wide range of sources, 
both purposively sampled and cross- trial. The purposive 
sampling of practices mitigated the limitation that only 
a subset of practices and individuals involved in the trial 
were interviewed or observed, and we explored the full 
range of variation in implementation and reach (table 2), 
including quantitative process data from all practices. In 
accordance with published guidance,10 the process evalu-
ation analysis took place blind to the trial results.
Comparison to other literature
An aim of the 3D process evaluation was to examine imple-
mentation fidelity to distinguish between implementa-
tion failure and intervention failure in the event of a null 
result. This distinction matters because it is important to 
avoid discarding a potentially effective intervention that 
was poorly implemented.10 29 30 Implementation difficul-
ties and deficiencies are not infrequently identified in 
effectiveness evaluations of complex healthcare delivery 
interventions31–34 but are not always elucidated.20 35 In 
this study, we found evidence of a degree of implementa-
tion failure and, in addition to identifying poorly imple-
mented components, we have considered reasons for 
poor implementation and whether they are modifiable. 
Non- modifiable reasons include unexpected events in 
individual practices, most commonly staff leaving and not 
being easily replaceable. Potentially modifiable reasons 
for adoption problems include the individual choices 
practices made about arranging reviews, influenced by 
practice size and existing recall systems, but implemen-
tation was also affected by the research trial context. 
Implementation in these circumstances is short term, and 
only applies to a subset of patients, with the majority still 
receiving usual care, which increases the risk of confusion 
and duplication. This circumstance influenced adminis-
trative choices made by practices, which in turn affected 
implementation.
The role of intervention design and setup, including 
training provided by research teams to practices, is signif-
icant and modifiable. In common with other research 
teams, we experienced difficulty in establishing a new way 
of working,36 37 although care did change enough that 
patients reported statistically significant changes in their 
experience of care in the intended direction (eg, having 
a greater sense of being consulted about their experience 
of health) and greater satisfaction with their care.12 The 
evidence suggested that this was attributable to the design 
of the intervention reviews (longer, comprehensive and 
asking first about the patient’s concerns),14 but there was 
also evidence that intervention design negatively affected 
implementation in some potentially modifiable ways. 
Implementation of health plans suffered from insufficient 
training and a lack of coherence between the health plan 
format and GP current practice, clearly suggesting that 
intervention design relating to both these aspects could 
be improved. Professional perceptions that some patients 
were unprepared to engage in health planning suggests 
that additional patient- targeted intervention components 
and/or better clinician training addressing attitudes and 
barriers to engaging in health planning and supporting 
self- management38 might facilitate collaboratively 
agreeing a plan of action. Many professionals did not see 
value for many patients in doing a second comprehensive 
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review in the same year, which likely contributed to lower 
reach for second reviews, and suggests that more targeted 
follow- up might have been a better design than routine 
rereview for all.
Our overall judgement was that there was, therefore, 
evidence of both implementation failure and interven-
tion failure, but that these were linked rather than truly 
distinct because in this case aspects of intervention design 
influenced implementation. Improvements in interven-
tion design could be focused on incorporating skills prac-
tice in the 3D training, better selection and preparation 
of patients, improvement to the health plan including a 
different format and greater patient ownership. We could 
also consider greater flexibility in follow- up reviews to 
allow varying intensity of follow- up tailored to patient 
need.
There is, however, a dilemma between ensuring an inter-
vention is implemented with high fidelity and allowing 
flexibility to suit local circumstances. The intervention 
design did allow for some adaptation ‘at the periphery’39 
and distinguished between core components that must 
be implemented in a particular form and less closely spec-
ified components whose form could vary, as long as the 
intended function was achieved.28 This is recommended 
to facilitate implementation in individual practices, but it 
is not straightforward to choose where to specify interven-
tion elements as ‘central’ and where to allow flexibility. 
In retrospect, some flexibility in follow- up reviews would 
be reasonable in future iterations of this type of inter-
vention. A further change, which might plausibly alter 
impact on HRQOL, would be to evaluate implementation 
over a longer period (although that clearly has significant 
cost implications) or as a whole practice improvement 
intervention delivered to all eligible patients, rather than 
running a parallel system of care for individual trial partic-
ipants. However, this creates the paradox that providing 
an intervention outside the context of a research trial 
may be more likely to provide a true representation of 
its effectiveness, but the effectiveness cannot be proved 
without the research.
COnCluSIOnS
In the context of an intervention that followed the 
recommendations and best evidence for care of people 
with multimorbidity, where the trial provided strong 
evidence that there was no effect on the primary outcome 
of HRQOL but an improvement in patient- centred 
outcomes, we found evidence of both implementation 
and intervention failure. Although this challenges the 
assumption that implementation and intervention failure 
can be clearly distinguished, we believe that the distinc-
tion does provide a useful framework to help interpret 
trial findings and to systematically identify modifiable and 
non- modifiable factors to inform future implementation 
decisions. This paper provides a worked example of how 
to use these concepts in process evaluation. We conclude 
first, that in the case of the 3D trial a truer test of the 
intervention effectiveness might be achieved by modifi-
cations that support better implementation, including 
whole practice implementation over a longer period to 
allow embedding. Second, it is important to examine 
reasons for implementation deficiencies to determine 
whether there were implementation failures and the 
reasons for them and whether they might be modifi-
able in order to avoid discarding a potentially effective 
intervention.
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